Title : Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.

Pub. Date : 2018 Dec

PMID : 30248303






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 However, bumepamine suppressed NKCC1-dependent giant depolarizing potentials (GDPs) in neonatal rat hippocampal slices much less effectively than bumetanide and did not inhibit GABA-induced Ca2+ transients in the slices, indicating that bumepamine does not inhibit NKCC1. gdps solute carrier family 12 member 2 Rattus norvegicus